Cargando…
Defective antifungal immunity in patients with COVID-19
The COVID-19 pandemic has placed a huge strain on global healthcare and been a significant cause of increased morbidity and mortality, particularly in at-risk populations. This disease attacks the respiratory systems and causes significant immune dysregulation in affected patients creating a perfect...
Autores principales: | Morton, Charles Oliver, Griffiths, James S., Loeffler, Juergen, Orr, Selinda, White, P. Lewis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750792/ https://www.ncbi.nlm.nih.gov/pubmed/36531987 http://dx.doi.org/10.3389/fimmu.2022.1080822 |
Ejemplares similares
-
The Use of Host Biomarkers for the Management of Invasive Fungal Disease
por: Griffiths, James S., et al.
Publicado: (2022) -
A Novel Strategy to Identify Haematology Patients at High Risk of Developing Aspergillosis
por: Griffiths, James S., et al.
Publicado: (2021) -
Macrophage Inducible C-Type Lectin As a Multifunctional Player in Immunity
por: Patin, Emmanuel C., et al.
Publicado: (2017) -
Human and Murine Innate Immune Cell Populations Display Common and Distinct Response Patterns during Their In Vitro Interaction with the Pathogenic Mold Aspergillus fumigatus
por: Hellmann, Anna-Maria, et al.
Publicado: (2017) -
Natural Killer Cells in Antifungal Immunity
por: Schmidt, Stanislaw, et al.
Publicado: (2017)